Lantheus Holdings (LNTH) Raw Materials (2014 - 2026)

Lantheus Holdings (LNTH) posted quarterly Raw Materials of $25.8 million for Q1 2026, down 0.68% quarter-over-quarter from $25.9 million in Q4 2025.

Lantheus Holdings (LNTH) Raw Materials (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has reported Raw Materials for 7 consecutive years, with $25.8 million the latest figure, recorded in Q1 2026.

In Q1 2026, Raw Materials changed N/A year-over-year to $25.8 million; the TTM figure through Mar 2026 stood at $25.8 million (changed N/A YoY), while the FY2025 annual figure was $25.9 million, down 10.84% from the prior year.
Raw Materials slipped to $25.8 million in Q1 2026 per LNTH's latest filing, from $25.9 million in the prior quarter.
Across five years, Raw Materials topped out at $29.1 million in Q4 2024 and bottomed at $25.0 million in Q3 2025.
Historically, Raw Materials has averaged $26.4 million across 3 years, with a median of $25.9 million in 2025.
On a YoY basis, Raw Materials climbed as much as 10.84% in 2025 and fell as far as 10.84% in 2025.
Lantheus Holdings' Raw Materials stood at $29.1 million in 2024, then decreased by 10.84% to $25.9 million in 2025, then retreated by 0.68% to $25.8 million in 2026.
Business Quant data shows LNTH's Raw Materials at $25.8 million in Q1 2026, $25.9 million in Q4 2025, and $25.0 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-
10	Lantheus Holdings	6.54 Bn	5.94 Bn	241.86 Mn

Download Data